News
3 minute read

McDonnell Boehnen Hulbert & Berghoff LLP a Proud Sponsor of 2014 BIO IPCC Conference

McDonnell Boehnen Hulbert & Berghoff LLP is proud to be an official sponsor of the 2014 IPPC Conference set for April 23-25, 2014 in Palm Springs, California. The Conference began in 2004 as a service to BIO members – members of the BIO IP Counsels Committee, core R&D companies, and BIO member law firms and other service providers. The conference had two parts:

  • One or two in-person committee meetings where members receive updates from BIO and also have the opportunity to discuss recent challenges and experiences among industry colleagues.
  • Educational sessions sponsored by expert law firms in the IP sector to keep BIO members up to date on the latest industry issues and events.

 

In 2009, the meeting was opened to BIO non-members, including core R&D companies, government, academia, and service providers. The conference still consisted of educational sessions and a committee meeting, as it does today.

MBHB partners Kevin Noonan, Ph.D. and Donald Zuhn, Ph.D. are featured presenters for a presentation taking place from 3:30-4:30 p.m. on Wed., April 23:

Pre-Conference Workshop: Facing the Future of Biotech Patenting: How to Satisfy the Supreme Court and Have Valuable Claims, Too

Moderator: Don Zuhn, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP

Panelists:

  • Kevin Noonan, Ph.D., Partner, McDonnell Boehnen Hulbert & Berghoff LLP
  • David C. Hoffman, Ph.D., Senior Corporate Counsel, IP & Transactions, Genomic Health
  • Laurie Hill, Ph.D., Vice President & Deputy General Counsel, MedImmune
  • Remy Yucel, Ph.D., Director, Central Reexamination Unit, U.S. Patent & Trademark Office

 

The panel will discuss the effects of the Supreme Court’s Mayo and Myriad decisions, in view of PTO Guidances and practitioners’ experience in prosecution. The panel will also discuss recent court cases including Myriad’s various litigations, declaratory judgment actions against Myriad, and the Ariosa v. Sequenom case before the Federal Circuit. Finally, the panel will pose several hypotheticals involving claims to genetic diagnostic methods, nucleic acids and other natural products.

About the BIO IPCC Conference

The biannual BIO Intellectual Property Counsels Committee Conference offers timely, relevant educational sessions on the latest issues in the biotech IP sector, informal networking events designed to promote discussion and foster relationships among industry colleagues, and practical tips for attendees to use the next day. Over 100 attendees representing biotech and pharma companies, law firms, academia and government come together from the U.S. and abroad to attend this one of a kind event.

View complete details at http://www.bio.org/events/conferences/agenda